Uterine smooth muscle contraction pathway

The uterine smooth muscle contraction pathway encompasses the complex physiological and molecular mechanisms by which uterine myocytes (smooth muscle cells of the myometrium) generate contraction. Initiation typically involves hormonal (e.g., oxytocin, prostaglandins), neuronal, and local ion channel signaling that converge to raise intracellular Ca²⁺ levels. Calcium entry (primarily via L-type voltage-gated calcium channels) activates calmodulin, which in turn activates myosin light-chain kinase, leading to phosphorylation of myosin light chains and enabling cross-bridge cycling with actin for contraction. Contractile force is regulated by RhoA/Rho kinase signaling, actin cytoskeleton dynamics, and is influenced by physiological modulators such as progesterone, nitric oxide, and relaxin. Dysfunction or dysregulation of these mechanisms is central to key obstetric conditions such as preterm labor, postpartum hemorrhage, and dysmenorrhea.

Other names

Myometrial contraction pathwayUterine contraction pathwayUterine myocyte contraction signaling

Agonism of oxytocin receptor to trigger G-protein coupled signaling and Ca²⁺ release; Blockade of L-type calcium channels to inhibit Ca²⁺ influx and prevent contraction; Blockade of prostaglandin receptors to suppress local uterine activation.